Exploring The SARC044 Trial
Dr. Candace Haddox will present an overview of the Phase II SARC044 Clinical Trial.
Removing Roadblocks to a Cure – GISTT Summit 2024
Roadblocks to a cure - a review of first GISTT Summit 2024 in Essen, Germany by participant LRG Data Analyst Jerry Call.
Updates from CTOS
Dr. Alcindor will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference.
Know Your Mutation: Why is Biomarker Testing Important in GIST?
Michelle Harris and Calvin Chao of Tempus will discuss the importance of biomarker testing in GIST, the process of biomarker testing, how to get testing done for free through The LRG, and more.
IDRX-42: Trial Design & Emerging Data from StrateGIST 1
Dr. Suzanne George of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST.
Locoregional Therapies for Treatment of GIST in the Liver
Dr. Kim of Mount Sinai Medical Center will describe various locoregional therapies and their appropriate uses, as well as the role of locoregional therapies and systemic therapy in treating GIST when it metastasizes in the liver.
Managing Side Effects of GIST Therapies
Dr. Weiss of Washington University School of Medicine in St. Louis will provide an overview of GIST treatments and side effects as well as home management for each type of symptom.
GIST Awareness Day: A Focus on GIST Research
July 13th, GIST Awareness Day, is a time when GIST experts, patients, and caregivers come together to educate the public about this disease and advocate for finding a cure. The Life Raft Group invites [...]
Updates from ASCO
Dr. Herbert Loong will summarize abstracts and presentations that were presented during the American Society of Clinical Oncology (ASCO) which is an important conference in the oncology community where new scientific research updates are shared.
Educate Yourself on GIST Research
Jim Hughes outlines the importance of patients/caregivers researching their cancer in order to best advocate for themselves.